Regulatory Compliance Update Bulletin: Temperature Monitoring — June 2026
Regulatory Compliance Update Bulletin: Temperature Monitoring — June 2026
This bulletin summarises recent regulatory developments affecting temperature monitoring across the food, pharmaceutical, and medical device sectors. Temperature Indicators Ltd publishes these monthly updates to help quality managers, compliance officers, and supply chain teams stay informed of the changing requirements that govern cold chain integrity and temperature control. The developments below reflect publicly available information from official regulatory bodies as of June 2026.
1. FDA Food Traceability Rule (FSMA Section 204): Compliance Date Extended to July 2028
The U.S. Food and Drug Administration's Food Traceability Rule, established under Section 204 of the Food Safety Modernization Act (FSMA), has seen a significant change to its enforcement timeline. The original compliance date for persons subject to the recordkeeping requirements was 20 January 2026. However, following a Congressional directive in the Continuing Appropriations and Extensions Act of 2026, the FDA has confirmed it will not enforce the rule before 20 July 2028 — a 30-month extension that gives covered businesses considerably more time to prepare.
The rule applies to anyone who manufactures, processes, packs, or holds foods on the Food Traceability List, which includes many temperature-sensitive items such as soft cheeses, fresh-cut produce, ready-to-eat deli salads, and certain seafood. These products depend on rigorous cold chain control, and the traceability records that the rule requires sit alongside the temperature monitoring data that demonstrates a product was held safely throughout distribution.
Although enforcement has been delayed, quality teams should not treat the extension as a reason to pause preparation. Temperature monitoring records, lot-level traceability, and Critical Tracking Events remain central to a defensible food safety programme. Teams handling listed foods should review how their temperature indicators and data loggers integrate with traceability recordkeeping so that, when enforcement begins, cold chain evidence and traceability records align. The full announcement and supporting resources are available from the FDA at the FDA Food Traceability Rule update page.
2. FDA Quality Management System Regulation (QMSR) Now in Effect
The FDA's Quality Management System Regulation (QMSR) took effect on 2 February 2026, amending the medical device current good manufacturing practice requirements of 21 CFR Part 820. The QMSR incorporates by reference the international standard ISO 13485:2016, harmonising the FDA's framework with that used by regulators in other major markets and replacing much of the former Quality System Regulation. Technical amendments to the regulation were also published in the Federal Register in December 2025 ahead of the effective date.
This change affects finished device manufacturers who commercially distribute medical devices in the United States, including the many sterile services departments, device makers, and contract manufacturers that rely on temperature-controlled processes and sterilisation cycles. From 2 February 2026, the FDA began using an updated inspection programme (Compliance Program 7382.850) and retired the older device inspection documents. Investigators may review quality system records, including those created before the effective date.
For quality teams, the practical question is how temperature monitoring fits within an ISO 13485-aligned quality management system. Under ISO 13485, organisations must control and monitor the environmental conditions that can affect product conformity — which, for many devices, includes storage temperature, sterilisation process temperatures, and the cold chain for temperature-sensitive components. Teams should review their monitoring records, calibration documentation, and process validation evidence to confirm they meet the harmonised expectations. Full details are published by the FDA on the Quality Management System Regulation (QMSR) page.
3. USP General Chapter <1079.2> on Temperature Excursion Evaluation
The United States Pharmacopeia released a revision to General Chapter <1079.2> on the evaluation of temperature excursions, which became official on 1 August 2025 and is now a key reference for pharmaceutical storage and distribution. For the first time, the chapter makes excursion evaluation explicit, defining calculation windows, temperature thresholds, documentation requirements, and clear warnings against misuse of mean kinetic temperature (MKT).
The chapter affects pharmaceutical manufacturers, wholesalers, distributors, and anyone responsible for assessing whether a temperature excursion has compromised product quality. A notable clarification is that MKT cannot be used to justify an out-of-specification event simply because the temperature later returned within limits — MKT is calculated over 30 consecutive days using data from and including the high excursion, and is not a tool for retrospectively excusing a breach. The USP has also continued to expand the <1079> series, with a proposed new chapter <1079.5> on Transportation Lane Temperature Mapping and Qualification published for comment.
Quality teams in the pharmaceutical sector should review their excursion management procedures against the explicit expectations in <1079.2>, ensuring that documentation, calculation methodology, and decision criteria are robust and that staff understand the correct — and incorrect — application of MKT. Reliable, well-placed temperature indicators and data loggers are essential to capturing the continuous data these calculations depend on. More information on the USP <1079> series of good storage and distribution chapters is available from the United States Pharmacopeia.
4. Health Canada GUI-0069: Revised Environmental Control Guidelines
Health Canada has confirmed revisions to GUI-0069, its guidance on the control of drug products during storage and transportation. A significant conceptual shift is that the focus on "temperature" has been broadened to "environmental control," encompassing factors such as humidity, light, and physical stress in addition to temperature. The revised guidance also assigns responsibility for good manufacturing practice and GUI-0069 compliance across all parties in the supply chain.
The broadened scope now reaches product owners, third-party logistics providers, and carriers, and extends to veterinary products, clinical trial drugs, drug samples, and active pharmaceutical ingredients (APIs). This is a meaningful expansion: parties who may previously have considered themselves outside the strict scope of cold chain guidance now share clear responsibilities for maintaining and documenting environmental conditions.
Under the revised GUI-0069, organisations must demonstrate continuous temperature monitoring, calibrated sensors and alarms, validated storage equipment, qualified packaging and shipping lanes, and documented responses to excursions. Quality teams distributing drug products in or into Canada should map their responsibilities against the broadened scope and confirm that monitoring coverage extends across every party and product type now captured. The full guidance is available from Health Canada at the GUI-0069 guidance page.
5. USDA FSIS Updates Salmonella Performance Standards for Poultry
The USDA's Food Safety and Inspection Service (FSIS) updated its establishment-level Salmonella performance standard categories for raw poultry carcasses, raw chicken parts, and comminuted poultry products, with the updated categorisation reflected in the Meat, Poultry, and Egg Product Inspection Directory from 9 March 2026. FSIS has continued to identify the control of pathogenic Salmonella as a leading food safety priority.
While performance standards focus on pathogen reduction rather than temperature directly, temperature control is inseparable from Salmonella management. Chilling, cold storage, and maintaining temperature control during processing and distribution are core HACCP controls for limiting pathogen growth in poultry and other meat products. Establishments in higher performance-standard categories will face particular scrutiny of their food safety systems, and temperature records form part of the evidence that critical controls are working.
Poultry and meat processors should review how their temperature monitoring supports their HACCP plans, particularly at chilling and cold-holding steps, and ensure records are complete and verifiable. FSIS also sought comment during 2026 on renewing its Sanitation SOPs and Pathogen Reduction/HACCP information collection, signalling continued attention to these foundational programmes. Current FSIS announcements are published on the FSIS News and Press Releases page.
What This Means for Quality and Compliance Teams
A common thread runs through these developments: regulators across jurisdictions are tightening the expectations around how temperature and environmental conditions are monitored, documented, and defended. Whether it is the harmonisation of medical device quality systems under the FDA's QMSR, the explicit excursion-evaluation rules in USP <1079.2>, the broadened responsibilities under Health Canada's GUI-0069, or the traceability and pathogen-control expectations in the food sector, the underlying message is consistent — accurate, continuous, and well-documented temperature data is no longer optional.
For quality and compliance teams, this means treating temperature monitoring as a core part of the compliance record rather than an afterthought. Robust monitoring depends on reliable indicators and loggers, correct placement, sound calibration, and clear procedures for responding to excursions. It also depends on coordination across the supply chain, as several of these changes explicitly extend responsibility to logistics providers, carriers, and other parties who handle product in transit and storage.
Temperature Indicators Ltd works with food manufacturers, pharmaceutical distributors, sterile services departments, and logistics providers to match temperature monitoring solutions to specific regulatory and operational requirements. If you would like expert guidance on selecting and deploying the right indicators or loggers for your application, please contact our team.
Frequently Asked Questions
When does the FDA Food Traceability Rule now have to be complied with?
Following a Congressional directive, the FDA has confirmed it will not enforce the Food Traceability Rule (FSMA Section 204) before 20 July 2028 — a 30-month extension from the original 20 January 2026 date. Businesses handling foods on the Food Traceability List should continue preparing their recordkeeping and cold chain documentation in the meantime.
How does the FDA QMSR affect temperature monitoring for medical devices?
The QMSR, effective 2 February 2026, incorporates ISO 13485:2016 into 21 CFR Part 820. ISO 13485 requires organisations to control and monitor environmental conditions that affect product conformity, which for many devices includes storage temperature, sterilisation process temperatures, and cold chain conditions for sensitive components. Monitoring, calibration, and validation records should be reviewed to meet the harmonised expectations.
What is the key change in USP General Chapter <1079.2>?
USP <1079.2>, official since 1 August 2025, makes temperature excursion evaluation explicit by defining calculation windows, thresholds, and documentation requirements. Importantly, it warns that mean kinetic temperature (MKT) cannot be used to justify an out-of-specification excursion simply because the temperature later returned within range.
Who is responsible for compliance under Health Canada's revised GUI-0069?
The revised GUI-0069 assigns responsibility across all parties in the supply chain, including product owners, third-party logistics providers, and carriers. Its scope has also broadened from temperature alone to wider "environmental control" and now covers veterinary products, clinical trial drugs, drug samples, and active pharmaceutical ingredients.
About Temperature Indicators Ltd
Temperature Indicators Ltd is a global service provider specialising in temperature-sensitive labels, tags, and indicators for cold chain monitoring, process validation, and regulatory compliance. With 35 years of experience and warehouse stock in both the UK (Manchester) and the US (near Santa Barbara, California), we supply food manufacturers, pharmaceutical distributors, sterile services departments, and logistics providers worldwide with the temperature monitoring solutions they need to maintain compliance. Contact us for expert guidance on temperature monitoring for your application.
Legal Disclaimer
The information provided in this bulletin is intended for general informational purposes only and does not constitute legal, regulatory, or compliance advice. Regulatory requirements are subject to change and may vary by jurisdiction, product type, and business size. Organisations are responsible for ensuring their compliance with all applicable regulations. Temperature Indicators Ltd has made every effort to ensure the accuracy of the information presented based on publicly available sources as of the date of publication. This bulletin should not be relied upon as a substitute for independent legal or regulatory advice.
- Temperature Indicators Staff
